Banque Pictet & Cie SA acquired a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 11,792 shares of the financial services provider's stock, valued at approximately $439,000.
A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Balyasny Asset Management L.P. lifted its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after buying an additional 212,545 shares during the last quarter. Freestone Grove Partners LP purchased a new position in shares of Trupanion during the fourth quarter worth $7,776,000. First Trust Advisors LP purchased a new position in shares of Trupanion during the fourth quarter worth $7,083,000. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after purchasing an additional 144,828 shares during the last quarter.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the stock. Lake Street Capital cut their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a report on Friday, May 2nd. Piper Sandler lifted their price objective on shares of Trupanion from $52.00 to $62.00 and gave the company an "overweight" rating in a report on Thursday, July 3rd. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $53.80.
Read Our Latest Stock Report on TRUP
Insider Activity
In other news, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $45.86, for a total value of $183,440.00. Following the sale, the chief executive officer owned 118,784 shares in the company, valued at $5,447,434.24. This trade represents a 3.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO John R. Gallagher sold 4,000 shares of Trupanion stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total transaction of $191,600.00. Following the completion of the sale, the chief operating officer owned 26,966 shares in the company, valued at approximately $1,291,671.40. This trade represents a 12.92% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,562 shares of company stock worth $678,230 over the last 90 days. 5.42% of the stock is currently owned by company insiders.
Trupanion Price Performance
Shares of NASDAQ TRUP traded down $0.91 during trading on Friday, hitting $49.76. The company had a trading volume of 392,992 shares, compared to its average volume of 618,895. The stock has a fifty day simple moving average of $49.58 and a two-hundred day simple moving average of $43.83. Trupanion, Inc. has a fifty-two week low of $29.70 and a fifty-two week high of $57.90. The firm has a market capitalization of $2.13 billion, a price-to-earnings ratio of -497.55 and a beta of 1.82. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.38.
Trupanion (NASDAQ:TRUP - Get Free Report) last announced its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. Trupanion had a negative net margin of 0.32% and a negative return on equity of 1.33%. The business had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter last year, the business earned ($0.16) earnings per share. The company's revenue for the quarter was up 11.7% compared to the same quarter last year. On average, research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.
Trupanion Company Profile
(
Free Report)
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading

Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.